Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury

• Published in: Critical care (London, England) England), 2008-01, Vol.12 (4), p.R98-R98, Article R98
• Main Authors: Meier, Regula, Béchir, Markus, Ludwig, Silke, Sommerfeld, Jutta, Keel, Marius, Steiger, Peter, Stocker, Reto, Stover, John F
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose - analysis; Blood Glucose - metabolism; Blood sugar; Brain; Brain Injuries - blood; Brain Injuries - mortality; Female; Health aspects; Humans; Hypoglycemia - blood; Hypoglycemia - mortality; Injuries; Intensive Care Units - trends; Male; Measurement; Methods; Middle Aged; Physiological aspects; Retrospective Studies; Time Factors; Young Adult
• ISSN: 1364-8535; 1466-609X; 1364-8535
• DOI: 10.1186/cc6974

Hyperglycaemia is detrimental, but maintaining low blood glucose levels within tight limits is controversial in patients with severe traumatic brain injury, because decreased blood glucose levels can induce and aggravate underlying brain injury. In 228 propensity matched patients (age, sex and injury severity) treated in our intensive care unit (ICU) from 2000 to 2004, we retrospectively evaluated the influence of different predefined blood glucose targets (3.5 to 6.5 versus 5 to 8 mmol/l) on frequency of hypoglycaemic and hyperglycaemic episodes, insulin and norepinephrine requirement, changes in intracranial pressure and cerebral perfusion pressure, mortality and length of stay on the ICU. Mortality and length of ICU stay were similar in both blood glucose target groups. Blood glucose values below and above the predefined levels were significantly increased in the 3.5 to 6.5 mmol/l group, predominantly during the first week. Insulin and norepinephrine requirements were markedly increased in this group. During the second week, the incidences of intracranial pressure exceeding 20 mmHg and infectious complications were significantly decreased in the 3.5 to 6.5 mmol/l group. Maintaining blood glucose within 5 to 8 mmol/l appears to yield greater benefit during the first week. During the second week, 3.5 to 6.5 mmol/l is associated with beneficial effects in terms of reduced intracranial hypertension and decreased rate of pneumonia, bacteraemia and urinary tract infections. It remains to be determined whether patients might profit from temporally adapted blood glucose limits, inducing lower values during the second week, and whether concomitant glucose infusion to prevent hypoglycaemia is safe in patients with post-traumatic oedema.